Reports for SIVEM PHARMACEUTICALS ULC
Company Name
SIVEM PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
378 |
|
| Actual shortage: | 25 (7%) | |
| Anticipated shortage: | 6 (2%) | |
| Avoided shortage: | 14 (4%) | |
| Resolved: | 333 (88%) | |
Discontinuation Reports |
107 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 100 (93%) | |
| Reversed: | 7 (7%) | |
Late reports |
83 (17%) |
|
Overdue reports |
4 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Resolved | 2023-11-22 | 2024-02-03 | 211174 |
| TELMISARTAN HCTZ | 25MG 80MG | TABLET | Resolved | 2023-02-02 | 2024-02-03 | 183176 |
| TELMISARTAN HCTZ | 25MG 80MG | TABLET | Resolved | 2023-02-02 | 2024-02-03 | 183206 |
| QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Anticipated shortage | 2024-01-31 | 2024-01-31 | 217992 |
| DONEPEZIL | 10MG | TABLET | Anticipated shortage | 2024-01-31 | 2024-01-31 | 217983 |
| DONEPEZIL | 5MG | TABLET | Anticipated shortage | 2024-01-31 | 2024-01-31 | 217980 |
| OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-11-22 | 2024-01-31 | 211151 |
| TELMISARTAN | 40MG | TABLET | Actual shortage | 2023-11-22 | 2023-11-22 | 211180 |
| TELMISARTAN | 40MG | TABLET | Actual shortage | 2023-11-22 | 2023-11-22 | 211177 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2023-11-22 | 2023-11-22 | 211141 |
| ATENOLOL | 50MG | TABLET | Actual shortage | 2023-11-22 | 2023-11-22 | 211134 |
| ALENDRONATE | 70MG | TABLET | Resolved | 2022-02-22 | 2023-11-22 | 155399 |
| QUETIAPINE | 100MG | TABLET | Resolved | 2023-04-26 | 2023-08-16 | 190322 |
| DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-02-02 | 2023-04-26 | 183173 |
| PRAVASTATIN | 40MG | TABLET | Resolved | 2022-10-13 | 2023-01-10 | 171649 |
| PRAVASTATIN | 40MG | TABLET | Resolved | 2022-10-13 | 2023-01-10 | 171652 |
| PRAVASTATIN | 20MG | TABLET | Resolved | 2022-10-13 | 2023-01-06 | 171646 |
| PRAVASTATIN | 20MG | TABLET | Resolved | 2022-10-13 | 2023-01-06 | 171643 |
| PRAVASTATIN | 10MG | TABLET | Resolved | 2022-10-13 | 2023-01-06 | 171640 |
| PRAVASTATIN | 10MG | TABLET | Resolved | 2022-10-13 | 2023-01-06 | 171637 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53404 |
| ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53393 |
| ROSUVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53398 |
| ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53401 |
| ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53383 |
| ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53386 |
| ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53389 |
| ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53380 |
| NIFEDIPINE ER | 30MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-06-29 | 2018-06-30 | 53333 |
| NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-06-29 | 2018-06-30 | 53339 |
| MEMANTINE | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53283 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53327 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53318 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53321 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53324 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53300 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53303 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53306 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53291 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-06-29 | 2018-06-30 | 53294 |